Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update

被引：0
|
作者：
Martino, Bruno [1 ]
le Coutre, Philipp [2 ]
Griesshammer, Martin [3 ]
Illmer, Thomas [4 ]
Schlag, Rudolf
Waller, Cornelius F. [5 ]
Liberati, Anna Marina [6 ]
Schafhausen, Philippe [7 ]
Tavares, Renato S. [8 ]
Vannucchi, Alessandro M. [9 ]
Giraldo, Pilar [10 ,11 ]
Foltz, Lynda M. [12 ]
Raanani, Pia [13 ]
Gupta, Vikas [14 ]
Tannir, Bayane [15 ]
Ronco, Julian Perez [15 ]
Ghosh, Jaggannath [16 ]
Al-Ali, Haifa Kathrin [17 ]
机构：
[1] Osped Bianchi Melacrino Morelli, Reggio Di Calabria, Italy
[2] Charite, D-13353 Berlin, Germany
[3] Johannes Wesling Clin, Minden, Germany
[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[5] Univ Hosp Freiburg, Freiburg, Germany
[6] AO S Maria di Terni, Terni, Italy
[7] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany
[8] Univ Fed Goias, Goiania, Go, Brazil
[9] Univ Florence, Florence, Italy
[10] Miguel Servet Univ Hosp, Zaragoza, Spain
[11] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Zaragoza, Spain
[12] Univ British Columbia, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada
[13] Rabin Med Ctr, Petah Tiqwa, Israel
[14] Princess Margaret Canc Ctr, Toronto, ON, Canada
[15] Novartis Pharma AG, Basel, Switzerland
[16] Novartis Pharmaceut, E Hanover, NJ USA
[17] Univ Leipzig, D-04109 Leipzig, Germany
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] A Single-Arm, Open-Label, Expanded Access Study of Vemurafenib in Patients With Metastatic Melanoma in the United States
    Flaherty, Lawrence
    Hamid, Omid
    Linette, Gerald
    Schuchter, Lynn
    Hallmeyer, Sigrun
    Gonzalez, Rene
    Cowey, C. Lance
    Pavlick, Anna
    Kudrik, Fred
    Curti, Brendan
    Lawson, David
    Chapman, Paul B.
    Margolin, Kim
    Ribas, Antoni
    McDermott, David
    Flaherty, Keith
    Cranmer, Lee
    Hodi, F. Stephen
    Day, Bann-Mo
    Linke, Rolf
    Hainsworth, John
    CANCER JOURNAL, 2014, 20 (01): : 18 - 24
  • [22] Safety and Efficacy of Iguratimod in Patients with Active Rheumatoid Arthritis: A Multicenter, Single-Arm, Open-Label, Real World Study
    Mu, Rong
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [23] SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN ELDERLY PATIENTS (≥75 YEARS) WITH MYELOFIBROSIS (MF): AN ANALYSIS FROM THE PHASE 3B, EXPANDED-ACCESS JUMP STUDY
    Raanani, P.
    Gupta, V.
    Sadjadian, P.
    Al-Ali, H. K.
    Giraldo, P.
    Guglielmelli, P.
    Foltz, L.
    Tavares, R.
    Zaritksey, A.
    Bouard, C.
    Ronco, J. Perez
    Tiwari, R.
    Martino, B.
    HAEMATOLOGICA, 2017, 102 : 281 - +
  • [24] Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis (vol 105, pg 309, 2017)
    Komatsu, Norio
    Kirito, Keita
    Shimoda, Kazuya
    Ishikawa, Takayuki
    Ohishi, Kohshi
    Ohyashiki, Kazuma
    Takahashi, Naoto
    Okada, Hikaru
    Amagasaki, Taro
    Yonezu, Toshio
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (03) : 387 - 387
  • [25] Efficacy and safety of ruxolitinib in patients with lower risk myelofibrosis: A single-arm, exploratory and prospective study.
    Hu, Shiwei
    Yang, Xiudi
    Tong, Hongyan
    Jin, Jie
    Huang, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study
    Ramanan, Ezhil Arasan
    Ravi, Sailatha
    Anbu, K. R. Radha
    Michael, Margaret
    DERMATOLOGY RESEARCH AND PRACTICE, 2020, 2020
  • [27] A subgroup analysis of JUMP, a phase IIIb, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis in a Brazilian cohort
    Tavares, Renato
    Souza, Carmino Antonio De
    Paley, Carole
    Bouard, Catherine
    Tiwar, Ranjan
    Pasquini, Ricardo
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (01) : 46 - 53
  • [28] Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study
    Onodera, Masafumi
    Uchiyama, Toru
    Ariga, Tadashi
    Yamada, Masafumi
    Miyamura, Takako
    Arizono, Hironori
    Morio, Tomohiro
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (07)
  • [29] A Multicenter, Open-Label, Single-Arm, Phase 2 Study to Evaluate the Efficacy and Safety of Hetrombopag in Patients with Severe Aplastic Anemia (SAA)
    Zhang, Fengkui
    Peng, Guangxin
    He, Guangsheng
    Chang, Hong
    Gao, Sujun
    Liu, Xinjian
    Chen, Tong
    Li, Pei
    Han, Bing
    Miao, Miao
    Ge, Zheng
    Ge, Xiaoyan
    Li, Fei
    Li, Yingmei
    Wang, Shunqing
    Wang, Yi
    Shen, Yaqi
    Tai, Yanfei
    Zhang, Tao
    Zhu, Bo
    Zou, Jianjun
    BLOOD, 2020, 136
  • [30] Efficacy and safety of sorafenib in combination with gemcitabine in patients with advanced hepatocellular carcinoma: A multicenter, open-label, single-arm phase II study
    Srimuninnimit, Vichien
    Sriuranpong, Virote
    Suwanvecho, Suthida
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (03) : 255 - 260
12345